Calls to suspend European sales of erlotinib for lung cancer.

MLA

Tanday, Sanjay. “Calls to Suspend European Sales of Erlotinib for Lung Cancer.” The Lancet. Respiratory Medicine, vol. 4, no. 9, Sept. 2016, p. 691. EBSCOhost, https://doi.org/10.1016/S2213-2600(16)30230-2.

APA

Tanday, S. (2016). Calls to suspend European sales of erlotinib for lung cancer. The Lancet. Respiratory Medicine, 4(9), 691. https://doi.org/10.1016/S2213-2600(16)30230-2

Chicago

Tanday, Sanjay. 2016. “Calls to Suspend European Sales of Erlotinib for Lung Cancer.” The Lancet. Respiratory Medicine 4 (9): 691. doi:10.1016/S2213-2600(16)30230-2.